Table 5.
Checkpoint blockade | ‘Classic’ type 1 | LADA | Fulminant diabetes | |
---|---|---|---|---|
Clinical features | ||||
Age at onset (range) | 61 years (22–84) | Childhood or adolescence Rarely adult |
>30 years | Adult |
Ethnicity | Both | Non-Asian | Non-Asian | Asian |
Symptoms at diagnosis | Acute (rarely subclinical) | Acute | Subclinical | Acute |
Ketoacidosis | Yes (76%) | Possible | Rarely | Yes |
Insulin required at diagnosis | Yes | Yes | No | Yes |
Biochemical features (at diagnosis) | ||||
C-peptide | Low or undetectable (84%) | Low or undetectable | Low or normal | Low or undetectable |
HbA1c (range) | 7.5% (5.4–11.4) | >6.35% | 7.86 | <8.7% |
Lipase | Elevated (52%) | Elevated (24%, DKA) | ? | Elevated (98%) |
Autoantibodies | Positive (53%) | Positive (>80%) | Positive | Negative |
Pathophysiology | ||||
HLA association | Suspected | High risk | High/mild risk | High risk |